Women's perceptions of hormone replacement therapy: risks and benefits (1980–2002). A literature review

References

• Barlow DH, Grosset KA, Hart H, Hart DM. A study of the experience of Glasgow women in the climacteric years. Br J Obstet Gynaecol 1989;96:1192–7
   PubMedGoogle Scholar
• Spector TD. Use of oestrogen replacement therapy in high risk groups in the United Kingdom. Br Med J 1989;299:1434–5
   PubMed Web of Science ®Google Scholar
• Sinclair HK, Bond CM, Taylor RJ. Hormone replacement therapy: a study of women's knowl-edge and attitudes. Br J Gen Pract 1993;43:365–70
   Google Scholar
• Rabin DS, Cipparrone N, Linn ES, Moen M. Why menopausal women do not want to take hormone replacement therapy. Menopause 1999;6:61–7
   PubMed Web of Science ®Google Scholar
• Woods NF, Mitchell ES. Patterns of depressed mood in midlife women: observations from the Seattle Midlife Women's Health Study. Res Nurs Health 1996;19:111–23
   PubMed Web of Science ®Google Scholar
• Shelley JM, Smith AMA, Dudley E, Denner-stein L. Use of hormone replacement therapy by Melbourne women. Aust J Public Health 1995; 19:387–92
   PubMedGoogle Scholar
• Wilkes HC, Meade TW. Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research frame-work. Br Med J 1991;302:1317–20
   PubMed Web of Science ®Google Scholar
• Oddens BJ, Boulet MJ. Hormone replacement therapy among Danish women aged 45-65 years: determinants and compliance. Obstet Gynecol 1997;90:269–77
   PubMed Web of Science ®Google Scholar
• Oddens BJ, Boulet MJ, Lehert P, Visser AP. Has the climacteric been medicalized? A study on the use of medication for climacteric complaints for four countries. Maturitas 1992;15:171–5
   PubMed Web of Science ®Google Scholar
• Barentsen R, Foekema HA, Bezmer W, van Stiphout FLM. The view of women aged 45–65 and their partners on aspects of the climacteric phase of life. Eur J Obstet Gynecol Reprod Biol 1994;57: 95–101
   Google Scholar
• Koster A. Hormone replacement therapy: use patterns among 51-year-old Danish women. Maturitas 1990;12:345–56
   PubMed Web of Science ®Google Scholar
• Mattson L, Stadberg E, Milson I. Management of hormone replacement therapy: the Swedish experience. Eur J Obstet Gynecol Reprod Biol 1996;64(Suppl 1):S3—S5
   Google Scholar
• Pedersen SH, Jeune B. Prevalence of hormone replacement therapy in a sample of middle-aged women. Maturitas 1988;9:339–45
   PubMed Web of Science ®Google Scholar
• Hemminki E, Kennedy DL, Baum C. Pres-cribing of noncontraceptive estrogens and progestins in the United States 1974–1986. Am J Public Health 1988;78: 1478–81
   Google Scholar
• Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536–45
   PubMed Web of Science ®Google Scholar
• Stafford RS, Saglam D, Causino N. Low rates of hormone replacement visits to United States primary care physicians. Am J Obstet Gynecol 1997;177:381–7
   Google Scholar
• Faulkner DL, Young C, Hutchins D, McCol-lam JS. Patient noncompliance with hormone replacement therapy: a nationwide estimate using a large prescription claims database. Menopause 1998;5:226–9
   Google Scholar
• Hope S, Rees M. Why do British women start and stop hormone replacement therapy? J Br Menopause Soc 1995;1:26–8
   Google Scholar
• Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985;102: 319–24
   Google Scholar
• Johannes CB, Crawford SL, Pomer JG, McKinlay SM. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994;140:439–52
   PubMed Web of Science ®Google Scholar
• Klein R, Berlin L. Benefits and risks of hormone replacement therapy. In Parlik EJ, ed. Health Issues (1). Boston, USA: Birthauser, 1997
   Google Scholar
• Ravnikar VA. Compliance with hormone ther-apy. Am J Obstet Gynecol 1987;156:1332–4
   PubMed Web of Science ®Google Scholar
• Ringa V, Ledesert B, Gueguen, R, Schiele F, Breart G. Determinants of hormone replace-ment therapy in recently post-menopausal women. Eur J Obstet Gynecol Reprod Biol 1992;45:193–200
   PubMed Web of Science ®Google Scholar
• Ryan PJ, Harrison R, Blake GM, Fogelman I. Compliance with hormone replacement ther-apy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynaecol 1992;99: 325–8
   PubMedGoogle Scholar
• Cano A. Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre. Maturitas 1995; 20:91–9
   Web of Science ®Google Scholar
• Groeneveld FPMJ, Bareman FP, Barentsen R, Dokter HJ, Drogendijk AC, Hoes AW. Deter-minants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45–60 years. Maturitas 1995;20: 81–9
   Google Scholar
• Meyer D, Leventhal H, Gutmann M. Common-sense models of illness: the example of hyper-tension. Health Psychol 1989;4:115–35
   Google Scholar
• Gonder-Frederick LA, Cox DJ. Symptom per-ception, symptom beliefs and blood glucose discrimination in the self-treatment of insulin dependent diabetes. In Skelton JA, Croyle RT, eds. Mental Representation in Health and Illness. New York, USA: Springer-Verlag, 1991
   Google Scholar
• Home R, Weinman J. Patients' beliefs about prescribed medicines and their role in adher-ence to treatment in chronic physical illness. J Psychosom Res 1999;47:555–67
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E. Prevalence, initiation, and continuation of hormone replacement therapy. J Women's Health 1995;4:143–8
   Google Scholar
• Hibbard JH, Hampson SE. Enhancing women's partnership with healthcare providers in hor-mone replacement therapy decision-making: research and practice directions. J Women Aging 1993;5:17–29
   Google Scholar
• NHS Centre for Reviews and Dissemination. Undertaking systematic reviews of research and effectiveness. CRD guidelines for those carry-ing out or commissioning reviews. CRD Report 1996;4:1–50
   Google Scholar
• Chalmers I, Altman DG. Systematic Reviews. London: British Medical Journal Publishing Group, 1995
   Google Scholar
• Goodman C. Literature Search and Evidence Interpretation for Assessing Health Care Prac-tices. Sweden: Swedish Council on Technology Assessment in Health Care, 1993
   Google Scholar
• Chalmers I, Dickerson T, Chalmers T. Getting to grips with Archie Cochrane's agenda: a register of all randomised controlled trials. Br Med J 1992;305:786–8
   Google Scholar
• Crow R, Gage H, Hampson S, Hart J, Kimber A, Thomas H. The role of expectancies in the placebo effect and their use in the delivery of health care: a systematic review. Health Tech-nology Assess 1999;3:1–96
   PubMedGoogle Scholar
• Ringa V, Ledesert B, Breart G. Determinants of hormone replacement therapy among postme-nopausal women enrolled in the French GAZEL cohort. Osteoporosis Int 1994;4: 16–20
   Google Scholar
• Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement therapy. A survey of women's knowledge and attitudes. Arch Intern Med 1989;149:133–6
   Google Scholar
• Woods NF, Saver B, Taylor T. Attitudes towards menopause and hormone therapy among women with access to health care. Menopause 1998;5:178–88
   Google Scholar
• Klempner LG. An updated analysis of women's attitudes on menopause where racial diversity is a variable. Dissertation Abstracts Int 1995; 56:1128–B
   Google Scholar
• Hunskaar S, Blacke B. Attitudes towards and level of information on perimenopausal and postmenopausal hormone replacement therapy among Norwegian women. Maturitas 1992;15: 183–94
   PubMed Web of Science ®Google Scholar
• Hope S, Wager E, Rees M. Survey of British women's views on the menopause and HRT. J Br Menopause Soc 1998;4:33–6
   Google Scholar
• Griffiths F, Jones K. The use of hormone replacement therapy: results of a community survey. Family Pract 1995;12:163–5
   PubMed Web of Science ®Google Scholar
• Lydakis C, Kerr H, Hutchings K, Lip G. Women's awareness of and attitudes towards hormone replacement therapy: ethnic differ-ences and effects of age and education. Int J Clin Pract 1989;52:7–12
   Google Scholar
• Roberts P. The menopause the hormone replacement therapy: views of women in general practice receiving hormone replace-ment therapy. Br J Gen Pract 1991;41:421–4
   PubMed Web of Science ®Google Scholar
• Saver B, Taylor T, Woods N. Use of hormone replacement therapy in Washington State. Is prevention being put into practice? J Family Pract 1999;48:364–71
   Google Scholar
• Ghali W, Freund K, Renee D, Ryan C, Moskowitz M. Menopause hormone therapy: physician awareness of patient attitudes. Am J Med 1997;103:3–10
   Google Scholar
• Jensen LB, Hilden J. Sociological and beha-vioural characteristics of perimenopausal women with an express attitude to hormone substitution therapy. Maturitas 1996;23: 73–83
   PubMed Web of Science ®Google Scholar
• Jones J. Hormone replacement therapy: wo-men's decision-making process. Social Work in Health Care 1999;28:95–111
   PubMed Web of Science ®Google Scholar
• Bond M, Bywaters P. Working it out for ourselves: women learning about hormone replacement therapy. Women's Studies Int Forum 1998;21:65–76
   Web of Science ®Google Scholar
• Woods N, Falk S, Saver B, et al. Deciding about using hormone therapy for prevention of diseases of advanced age: women's experience and implications for health care. Menopause 1997;4:105–14
   Google Scholar
• Hunter M, O'Dea I, Britten N. Decision-making and hormone replacement therapy: a qualitative analysis. Soc Sci Med 1997;45:1541–8
   PubMed Web of Science ®Google Scholar
• Griffiths F. Women's control and choice regarding HRT. Soc Sci Med 1999;49:469–81
   PubMed Web of Science ®Google Scholar
• Mansfield PK, Voda AM. Hormone use among middle-aged women: Results of a three year study. Menopause 1994;1:99–108
   Web of Science ®Google Scholar
• Andrist L. The impact of media attention, family history, politics, and maturation on women's decisions regarding hormone replace-ment therapy. Health Care Women Int 1998; 19:243–60
   PubMedGoogle Scholar
• Wind Wardell DW, Engebretson JC. Women's anticipation of hormonal replacement therapy. Maturitas 1995;22:177–83
   PubMed Web of Science ®Google Scholar
• Griffiths F. Women's health concerns. Is the promotion of hormone replacement therapy for prevention important to women? Family Pract 1995;12:54–9
   Google Scholar
• Morrison KL. Women's knowledge of meno-pause and estrogen replacement therapy: a survey conducted in Alaska. Dissertation Abstracts Int 1993;55:601–B
   Google Scholar
• Hunt K. Perceived value of treatment among a group of long-term users of hormone replace-ment therapy. J R Coll Gen Pract 1988;38: 398–40
   PubMedGoogle Scholar
• Abraham S, Perz J, Clarkson R, Llewellyn-Jones D. Australian women's perceptions of hormone replacement therapy. Maturitas 1995; 21:91–5
   Google Scholar
• Blumberg G, Kaplan B, Rabinerson D, Gold-man G, Kitai E, Neri A. Women's attitudes towards menopause and hormone replacement therapy. Int J Gynecol 1996;54:271–7
   Google Scholar
• Col NF, Eckman MH, Karas RH, et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. J Am Med Assoc 1997;277:1140–7
   PubMed Web of Science ®Google Scholar
• Draper J, Roland M. Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis. Br Med J 1990;300: 786–8
   PubMed Web of Science ®Google Scholar
• Egeland G, Matthews K, Kuller L, Kelsey S. Characteristics of noncontraceptive hormone users. Prey Med 1988;17:403–11
   PubMed Web of Science ®Google Scholar
• Groeneveld FPMJ, Bareman FP, Barentsen R, Dokter HJ, Drogendijk AC, Hoes AW. Rela-tionships between attitude towards menopause, well-being and medical attention among wo-men aged 45-60 years. Maturitas 1993;17:77–88
   PubMed Web of Science ®Google Scholar
• Halbert DR, Lloyd T, Rollings N, Kowalski W, Mauger E. Hormone replacement therapy usage: a 10-year experience of a solo practi-tioner. Maturitas 1998;29: 67–73
   Google Scholar
• Hee P. Compliance to estrogen treatment one to three years after hysterectomy and bilateral salpingoophorectomy. The cohort's lifestyle, knowledge of ERT, benefits etc. Acta Obstet Gynecol Scand 1999;78:534–9
   PubMed Web of Science ®Google Scholar
• Hunter K, Liao K. Intentions to use hormone replacement therapy in a community sample of 45-year-old women. Maturitas 1994;20:13–23
   PubMed Web of Science ®Google Scholar
• Hunter MS, O'Dea I. Perceptions of future health risks in mid-aged women: estimates with and without behavioural changes and hormone replacement therapy. Maturitas 1999;33:37–43
   PubMed Web of Science ®Google Scholar
• Jeffe JB, Frieman M, Fisher EB. Women's reasons for using post-menopausal hormone replacement therapy: preventative medicine or therapeutic aid? Menopause 1996;3:106–16
   Google Scholar
• Kadri A. Hormone replacement therapy: a survey of perimenopausal women in the com-munity setting. Br J Gen Pract 1991;41:109–12
   PubMed Web of Science ®Google Scholar
• Logothetis M. Women's decisions about estro-gen replacement therapy. W J Nurs Res 1991; 13:459–74
   Google Scholar
• Marmoreo J, Brown JB, Batty HR, Cummings S, Powell M. Hormone replacement therapy: determinants of women's decisions. Patient Educ Counsel 1998;33:289–98
   PubMed Web of Science ®Google Scholar
• McKinlay J, McKinlay SM, Brambilla D. Health status and utilization behavior asso-ciated with menopause. Am J Epidemiol 1987; 125:110–21
   Google Scholar
• McKinney KA, Severino M, McFall P, Burry K, Thompson W. Treatment-seeking women at menopause: a comparison between two uni-versity menopause clinics. Menopause 1998; 5:174–7
   Google Scholar
• Newton K, LaCroix A, Leveille S, Rutter C, Keenan N, Anderson A. Women's beliefs and decisions about hormone replacement therapy. J Women's Health 1997;6:459–65
   PubMed Web of Science ®Google Scholar
• O'Leary CJ. Why women choose not to take hormone therapy. Women's Health Forum 1994;3:1–3
   Google Scholar
• Rothert M, Rovner D, Holmes M, et al. Women's use of information regarding hormone replace-ment therapy. Res Nurs Health 1990;13:355–66
   PubMed Web of Science ®Google Scholar
• Schmitt N, Gogate J, Rothert M, et al. Capturing and clustering women's judgement policies: the case of hormonal therapy for menopause. Gerontology 1991;46:92–101
   Google Scholar
• Seto TB, Taira DA, Davis RB, Safran C, Phillips RS. Effects of physician gender on the prescrip-tion of estrogen replacement therapy. J Gen Intern Med 1996;11:197–203
   Google Scholar
• Stadberg E, Mattson LA, Milsom I. Women's attitudes and knowledge about the climacteric period and its treatment. Maturitas 1997;27: 109–16
   Google Scholar
• Swiers D. Women's knowledge of HRT and the prevention of osteoporosis. Nurs Standard 1996;10:35–7
   PubMedGoogle Scholar
• Utian W, Schiff I. NAMS/Gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replace-ment therapy. Menopause 1994;1:39–48
   Web of Science ®Google Scholar
• Vassilopoulou-Sellin R, Zolinski C. Estrogen replacement therapy in women with breast cancer: a survey of patient attitudes. Am J Med Sci 1992;304:145–9
   Google Scholar
• Wren B, Brown L. Compliance with hormone replacement therapy. Maturitas 1991;13:17–21
   PubMed Web of Science ®Google Scholar
• Gupta S, Forbes N, Kirkman R. Attitudes to menopause and hormone replacement therapy among Asian and Caucasian women general practitioners. Maturitas 2001;39:169–75
   Google Scholar
• Akong J, Hoon KNY, Dial C, et al. Hormone replacement therapy - knowledge, attitudes and practices of women attending a gynaecol-ogy outpatient clinic in Trinidad. W Ind Med J 2001;50:155–8
   PubMed Web of Science ®Google Scholar
• Lomranz J, Becker D, Eyal N, Pines A, Mester R. Attitudes towards hormone replacement therapy among middle-aged women and men. Eur J Obstet Gynecol Reprod Biol 2000;93: 199–203
   Google Scholar
• Coo H, O'Connor KS, Hunter D. Women's knowledge of hormone therapy. Patient Educ Counsel 2001;45:295–301
   PubMed Web of Science ®Google Scholar
• Armstrong K, Popik S, Guerra C, Ubel PA. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy. Med Decis Making 2000;20:308–13
   PubMed Web of Science ®Google Scholar
• Oddens B, Boulet M, Lehert P, Visser A. A study on the use of medication for climacteric complaints in Western Europe: II. Maturitas 1994;19:1–12
   PubMed Web of Science ®Google Scholar
• Conrad P. The meaning of medications: an-other look at compliance. Soc Sci Med 1985; 20:29–37
   PubMed Web of Science ®Google Scholar
• Echabe AE, Guillen CS, Ozmaiz JA. Represen-tations of health, illness and medicines: coping strategies and health promoting behaviour. Br J Clin Psychol 1992;31:339–49
   Google Scholar
• Home R. Representations of medication and treatment: advances in theory and measure-ment. In Petrie KJ, Weinman J, eds. Perceptions of Health, and Illness: Current Research and Applications. London: Harwood Academic, 1997:155–88
   Google Scholar
• Home R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire (BMQ): a new method for assessing the cognitive representa-tion of medication. Psychol Heath 1999;14:1–24
   Google Scholar
• Mansbridge B, Fisher S. Public knowledge and attitudes about diazepam. Psycho pharmacol-ogy 1984;82:225–8
   PubMed Web of Science ®Google Scholar
• Holte A. Prevalence of climacteric complaints in a representative sample of middle-aged women in Oslo, Norway. J Psychosom Obstet Gynecol 1991;12:303–17
   Web of Science ®Google Scholar
• Oldenhave A, Jaszmann LJB, Haspels AA, Everaerd WTAM. Impact of climacterium on well-being. Am J Obstet Gynecol 1993;168: 772–80
   PubMed Web of Science ®Google Scholar
• Kaufert PA, Gilbert P, Hassard T. Researching the symptoms of menopause: an exercise in methodology. Maturitas 1988;10:117–31
   Google Scholar
• Mikkelsen A, Holte A. A factor analytic study of climacteric symptoms. Psych Soc Sci 1982;2: 35–9
   Google Scholar
• Ross D. HRT and breast cancer: is there a problem? Trends Urol Gynaecol Sex Health 1997;2:9–12
   Google Scholar
• Garton M, Reid D, Elaine R. The climacteric, osteoporosis and hormone replacement: views of women aged 45–49. Maturitas 1995;21: 7–15
   Google Scholar
• Kilshaw J. Patients' views of HRT. Practitioner 1990;234:488
   PubMedGoogle Scholar
• Liao KLM, Hunter MS. Knowledge and beliefs about menopause in a general population sample of mid-aged women. J Reprod Inf. Psych 1995;13:101–14
   Google Scholar
• Griffiths F. Women's decisions about whether or not to take hormone replacement therapy: influence of social and medical factors. Br J Gen Pract 1995;45:477–80
   PubMed Web of Science ®Google Scholar
• Bryce FC, Lifford RJ. General practitioners' use of hormone replacement therapy in Yorkshire. Eur J Obstet Gynecol 1990;37:55–61
   PubMed Web of Science ®Google Scholar
• Kaufert P, Boggs PP, Ettinger B, Woods NF, Utian WH. Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 menopause survey. Menopause 1998;5: 197–202
   Google Scholar
• Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991; 115:455–6
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Palmer J, Rao R, Adams-Camp-bell L. Correlates of post-menopausal female hormone use among black women in the United States. Obstet Gynecol 1998;91:454–8
   Google Scholar
• Salamone LM, Pressman AR, Blake GM, Fogelman I. Estrogen replacement therapy: a survey of older women's attitudes. Arch Intern Med 1996;156:1293–7
   PubMed Web of Science ®Google Scholar
• Scalley EK, Henrich JB. An overview of estrogen replacement therapy in postmenopau-sal women. J Women's Health 1993;2:289–94
   Google Scholar
• Cauley J, Cummings S, Black D, Mascioli S, Seeley D. Prevalence and determinants of estrogen replacement therapy in elderly wo-men. Am J Obstet Gynecol 1990;163:1438–44
   Google Scholar
• Handa VL, Landerman R, Hanlon JT, Harris T, Cohen HJ. Do older women use estrogen replacement therapy? Data from the Duke established populations for epidemiologic stu-dies of the elderly (EPESE). J Am Geriatric Soc 1996;44:1–6
   Google Scholar
• Persson I, Adami HO, Lindberg BS, Johansson EDB, Manell P. Practice and patterns of estrogen treatment in climacteric women in a Swedish population. Acta Obstet Gynecol Scand 1983;62:289–96
   PubMed Web of Science ®Google Scholar
• Vihtamaki T, Savilahti R, Tuimala R. Why do postmenopausal women discontinue hormone replacement therapy? Maturitas 1999;33: 99–105
   Google Scholar
• Berman RS. Patient compliance of women taking estrogen replacement therapy. Drug Info J 1997;31:71–83
   Google Scholar
• Collins A, Landgren B-M. Psychosocial factors associated with the use of hormonal replace-ment therapy in a longitudinal follow-up of Swedish women. Maturitas 1997;28:1–9
   Google Scholar
• Couzi RJ, Helzlsouer KJ, Fetting JH. Preva-lence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncology 1995;13:2737–44
   Google Scholar
• Ettinger B, Pressman A, Silver P. Effect of age on reasons for initiation and discontinuation of hormone replacement therapy. Menopause 1999;6:282–9
   Google Scholar
• Griffiths F, Convery B. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of os-teoporosis, and after hysterectomy. Br J Gen Pract 1995;45:355–8
   PubMed Web of Science ®Google Scholar
• Holmes-Rovner M, Padonu G, et al. African-American Women's attitudes and expectations of menopause. Am J Prey Med 1996;12:420–3
   Google Scholar
• Isaacs AJ, Britton AR, McPherson K. Why do women doctors in the UK take hormone replacement therapy? J Epidemiol Commun Health 1997;51:373–7
   Google Scholar
• Karakoc B, Erenus M. Compliance considera-tions with hormone replacement therapy. Menopause 1998;5:102–6
   PubMed Web of Science ®Google Scholar
• Lauver D, Settersten L, Marten S, Halls J. Explaining women's intentions and use of hormones with menopause. Res Nurs Health 1999;22:309–20
   PubMed Web of Science ®Google Scholar
• MacDougall LA, Barzilay JI, Helmick CG. The role of personal health concerns and knowledge of the health effects of hormone replacement therapy (HRT) on the ever use of HRT by menopausal women, aged 50–54 years. J Womens Health Gend Based Med 1999;8: 1203–11
   Google Scholar
• Roberts J, Baumann B, Chambers L. Women and decision making: hormone replacement therapy. Women's Health Issues 1995;5: 40
   Google Scholar
• King KB, Quinn JR, Delehanty JM, et al. Reasons for use of hormone replacement therapy in women undergoing coronary angio-graphy. J Womens Health Gend Based Med 2000;9:1081–7
   PubMedGoogle Scholar
• Hundrup YA, Obel EB, Rasmussen NK, Philip J. Use of hormone replacement therapy among Danish nurses in 1993. Acta Obstet Gynecol Scand 2000;79:194–201
   PubMed Web of Science ®Google Scholar
• Li C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD, The Women's Health in Lund Area (WHILA) Study. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. Meno-pause 2000;7:273–81
   Google Scholar
• MacLaren A, Woods NF. Midlife women making hormone therapy decisions. Women's Health Issues 2001;11:216–20
   PubMed Web of Science ®Google Scholar
• North FM, Sharples K. Changes in the use of hormone replacement therapy in New Zealand from 1991-1997. NZ Med J 2001;114:250–3
   PubMedGoogle Scholar
• MacLennan AH, Taylor AW, Wilson DH. Changes in the use of hormone replacement therapy in South Australia. Med J Australia 1995;162:420–42
   Google Scholar
• Wysowski DK, Golden L, Burke L. Use of menopausal estrogens and medroxyprogester-one in the United States. Obstet Gynecol 1995;85:6–10
   Google Scholar
• Crosignani PG, Rubin BL. Continuation rates for oral contraceptives and hormone replace-ment therapy. Hum Reprod 2000;15:1865–71
   PubMed Web of Science ®Google Scholar
• Bjorn I, Backstrom T. Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy. Maturitas 1999;32:77–86
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Figueras F, Sanjuan A, et al. Long-term compliance with estrogen replace-ment therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation. Menopause 1999;6:307–11
   Google Scholar
• Chung THK, Lau TK, Cheung LP, Haines CJ. Compliance with hormone replacement ther-apy in Chinese women in Hong Kong. Maturitas 1998;28:213–19
   PubMed Web of Science ®Google Scholar
• Hammond CB. Women's concerns with hor-mone replacement therapy — compliance issues. Fertil Steril 1994;62:1575–605
   Google Scholar
• Natchigall LE. Enhancing patient compliance with hormone replacement therapy at meno-pause. Obstet Gynecol 1990;75:775–8
   PubMedGoogle Scholar
• Stumpf PG, Trolice MP. Compliance problems with hormone replacement therapy. Obstet Gynecol Clin N Am 1994;21:219–28
   PubMed Web of Science ®Google Scholar
• den Tonkelaar I, Oddens BJ. Determinants of long-term hormone replacement therapy and reasons for early discontinuation. Obstet Gy-necol 2000;95:507–12
   PubMed Web of Science ®Google Scholar
• Leung TN, Haines CJ, Chung TKH. Five-year compliance with hormone replacement therapy in postmenopausal Chinese women in Hong Kong. Maturitas 2001;39:195–201
   Google Scholar
• Wallace WA, Price VH, Elliot CA, MacPherson MBA, Scott BW. Hormone replacement ther-apy acceptability to Nottingham post-menopausal women with a risk factor for osteoporosis. J R Soc Med 1990;83:699–701
   Google Scholar
• Limouzin-Lamothe M-A. What women want from hormone replacement therapy: results of an international survey. Eur J Obstet Gynecol Reprod Biol 1996;64:521–524
   Google Scholar
• Leveille SG, LaCroix AZ, Newton KM, Keenan NL. Older women and hormone replacement therapy: factors influencing late life initiation. J Am Geriatric Soc 1997;45:1496–500
   PubMed Web of Science ®Google Scholar
• Eiken P, Kolthoff N. Compliance with long-term oral hormonal replacement therapy. Maturitas 1995;22:97–101
   PubMed Web of Science ®Google Scholar
• Osborn BH, Couchman GM, Siegler IC, Bastian LA. Osteoporosis risk factors: associa-tion with use of hormone replacement therapy and with worry about osteoporosis. Women's Health Issues 1999;9:278–85
   Web of Science ®Google Scholar
• Jeffe DB, Binder EF, Williams DB, Kohrt WM. Frail older women's participation in a trial of hormone replacement therapy: perceived ben-efits and concerns. Menopause 2001;8:127–34
   PubMed Web of Science ®Google Scholar
• Fauconnier A, Ringa V, Delanoe D, Falissard B, Breart G. Use of hormone replacement therapy: women's representations of meno-pause and beauty care practices. Maturitas 2000;35:215–28
   Google Scholar
• Buist DSM, LaCroix AZ, Newton KM, Keenan NL. Are long-term hormone replacement ther-apy users different from short-term and never users? Am J Epidemiol 1999;149:275–81
   PubMed Web of Science ®Google Scholar
• Connelly MT, Ferrari N, Hagen N, Inui TS. Patient-identified needs for hormone replace-ment therapy counselling: a qualitative study. Ann Intern Med 1999;131:265–8
   PubMed Web of Science ®Google Scholar
• Becker H, Stuifbergen AK, Gordon D. The decision to take hormone replacement therapy among women with disabilities. W J Nurs Res 2002;24:264–81
   Google Scholar
• Finley C, Gregg EW, Solomon LJ, Gay E. Disparities in hormone replacement therapy use by socioeconomic status in a primary care population. J Commun Health 2001;26:39–50
   PubMed Web of Science ®Google Scholar
• Quine L, Rubin R. Attitude, subjective norm and perceived behavioural control as predictors of women's intentions to take hormone repla-cement therapy. Br J Health Psychol 1997;2: 199–216
   Web of Science ®Google Scholar
• Vassilopoulou-Sellin R, Klein MJ. Estrogen replacement therapy after treatment for loca-lized breast carcinoma: patient responses and opinions. Cancer 1996;78:1043–8
   Google Scholar
• Hahn RC, Natchigall RD, Davies TC. Compliance difficulties with progestion-supple-mented estrogen replacement therapy. J Fam Pract 1984;18:431–4
   Google Scholar
• Coope J, Marsh J. Can we improve compliance with long-term HRT? Maturitas 1992;15: 151–8
   PubMed Web of Science ®Google Scholar
• Mattson LA, Cullberg G, Samsioe G. Evalua-tion of a continuous oestrogen—progestogen regimen for climacteric complaints. Maturitas 1982;4:95–102
   Google Scholar
• Randall S. Problems encountered by long-term hormone replacement therapy users. How can compliance be improved? Br J Fam Plann 1990;16:101–5
   Google Scholar
• Regan MM, Emond SK, Attar& MJ, Parker RA, Greenspan SL. Why do older women discontinue hormone replacement therapy? J Womens Health Gend Based Med 2001;10: 343–50
   PubMedGoogle Scholar
• Reynolds RF, Obermeyer CM, Walker AM, Guilbert D. Side effects and sociobehavioral factors associated with the discontinuation of hormone therapy in a Massachusetts health maintenance organization. Menopause 2001;8: 189–99
   PubMed Web of Science ®Google Scholar